Glen Nowak is part of a $5 million five-year University of Georgia proposal submitted to the U.S. Food & Drug Administration

Glen Nowak is part of a $5 million five-year University of Georgia proposal submitted to the U.S. Food & Drug Administration in response to a call for proposals to improve the agency’s ability to engage with key stakeholders, patients, the public, communities and others on drug development policies and to improve the use of science in public, stakeholder and community engagement efforts.

Glen Nowak